-
1.
公开(公告)号:US20090192057A1
公开(公告)日:2009-07-30
申请号:US12053875
申请日:2008-03-24
申请人: Wayne W. Frenier , Diankui Fu , Stephen Nigel Davies , Murtaza Ziauddin , Zhijun Xiao , Bruno Lecerf , Helene Bulte , Michael Fuller
发明人: Wayne W. Frenier , Diankui Fu , Stephen Nigel Davies , Murtaza Ziauddin , Zhijun Xiao , Bruno Lecerf , Helene Bulte , Michael Fuller
IPC分类号: C09K8/86
CPC分类号: C09K8/74
摘要: In a method of treating a sandstone-containing formation penetrated by a wellbore, a treatment fluid comprising an aqueous fluid containing a Bronsted acid, a hydrogen fluoride source and an organic acid or salt thereof that is substantially soluble in the aqueous fluid is formed. The treatment fluid contains less than about 2% of fluoride (F−) by weight of the fluid and from 2% or less of sodium (Na+) by weight of the fluid. The treatment fluid is introduced into the formation through the wellbore as a single-stage without introducing an acid-containing fluid preflush into the formation prior to introducing the treatment fluid.
摘要翻译: 在处理由井眼渗透的含砂岩地层的方法中,形成包含基本上可溶于水性流体的含有布朗斯台德酸,氟化氢源及其有机酸或其盐的含水流体的处理流体。 处理液含有少于约2%的流体重量的氟化物(F-),和流体重量的2%或更少的钠(Na +)。 在引入处理流体之前,将处理流体作为单阶段通过井筒引入地层,而不将酸含量的流体预吹入地层中。
-
公开(公告)号:US20060118302A1
公开(公告)日:2006-06-08
申请号:US11280749
申请日:2005-11-16
申请人: Michael Fuller , Diankui Fu , Marieliz Garcia-Lopez De Victoria , Slaheddine Kefi , Mohan Panga
发明人: Michael Fuller , Diankui Fu , Marieliz Garcia-Lopez De Victoria , Slaheddine Kefi , Mohan Panga
CPC分类号: C09K8/74 , C09K8/602 , C09K2208/30 , C09K2208/32 , Y10S507/934
摘要: A method is described for treating a subterranean formation with a low viscosity fluid system that contains a viscoelastic surfactant at a concentration too low to viscosify the fluid, but that is concentrated in the formation so that the fluid system gels. The fluid also contains a formation-dissolving agent. The fluid is used in acidizing, acid fracturing, and diversion.
-
公开(公告)号:US20120048547A1
公开(公告)日:2012-03-01
申请号:US12868188
申请日:2010-08-25
申请人: Trevor Hughes , Evgeny Barmatov , Jill Geddes , Michael Fuller , Bruno Drochon , Sergey Makarychev-Mikhailov
发明人: Trevor Hughes , Evgeny Barmatov , Jill Geddes , Michael Fuller , Bruno Drochon , Sergey Makarychev-Mikhailov
CPC分类号: C09K8/80
摘要: Gravel packing a region of a wellbore is carried out using one or more hydrophobically-surfaced particulate materials as the gravel. Placing the gravel pack is carried out using an aqueous carrier liquid, with hydrophobic particulate material suspended in the liquid and a gas to wet the surface of the particles and bind them together as agglomerates. The presence of gas lowers the density of the agglomerates relative to the particulate material in them, so that transport of the particulates is improved. The invention enables the placing of longer, uniformly packed, gravel packs, especially in horizontal and near horizontal wellbores.
摘要翻译: 使用一个或多个疏水表面的颗粒材料作为砾石进行用于钻井的区域的砾石。 砾石包装的放置使用水性载体液体进行,其中悬浮在液体中的疏水性颗粒物质和气体以润湿颗粒表面并将其作为附聚物结合在一起。 气体的存在降低了聚集体相对于其中的颗粒材料的密度,从而提高了颗粒的输送。 本发明使得能够放置较长的均匀包装的砾石包装,特别是在水平和近水平井筒中。
-
公开(公告)号:US20080059240A1
公开(公告)日:2008-03-06
申请号:US11609443
申请日:2006-12-12
申请人: Prasant Potuluri , David Brady , Michael Fuller
发明人: Prasant Potuluri , David Brady , Michael Fuller
CPC分类号: G06F19/3462 , G06F19/00 , G06Q50/22 , G06Q50/24
摘要: Embodiments of the present invention relate to systems and methods for communicating pharmaceutical verification information between a server and a node using a network. A node includes a pharmaceutical identification and verification system. The verification information includes a known spectral signature of a known pharmaceutical and a corresponding known pharmaceutical name and dosage strength of the known pharmaceutical. The server stores the verification information in a server database. The node receives the verification information from the server, stores the verification information in the client database, reads a pharmaceutical name and dosage strength from a container enclosing a pharmaceutical, obtains a detected spectral signature for the pharmaceutical, and compares the detected spectral signature to the at least one known spectral signature. The pharmaceutical identification and verification system includes a static multimodal multiplex spectrometer. The verification information can also include a spectral signature of a known container.
摘要翻译: 本发明的实施例涉及用于在服务器和使用网络的节点之间传送药物验证信息的系统和方法。 节点包括药物识别和验证系统。 验证信息包括已知药物的已知光谱特征和已知药物的相应的已知药物名称和剂量强度。 服务器将验证信息存储在服务器数据库中。 节点从服务器接收验证信息,将验证信息存储在客户端数据库中,从包含药品的容器读取药品名称和剂量强度,获得检测到的药品光谱特征,并将检测到的光谱特征与 至少一个已知的光谱特征。 药物鉴定和验证系统包括静态多模式多重光谱仪。 验证信息还可以包括已知容器的光谱签名。
-
公开(公告)号:US09234415B2
公开(公告)日:2016-01-12
申请号:US12868177
申请日:2010-08-25
申请人: Trevor Hughes , Evgeny Barmatov , Jill Geddes , Michael Fuller , Bruno Drochon , Sergey Makarychev-Mikhailov
发明人: Trevor Hughes , Evgeny Barmatov , Jill Geddes , Michael Fuller , Bruno Drochon , Sergey Makarychev-Mikhailov
IPC分类号: E21B43/267 , E21B43/26 , C09K8/80 , C09K8/66 , C09K8/70
CPC分类号: C09K8/805 , C09K8/665 , C09K8/70 , C09K2208/28 , E21B43/267
摘要: A wellbore fluid comprises an aqueous carrier liquid, hydrophobic particulate material suspended therein and a gas to wet the surface of the particles and bind them together as agglomerates. The hydrophobic particulate material has a specified maximum volume median particle size d50 of not more than 200 micron, and/or a minimum surface area of at least 30 m2 per liter. Agglomerates of the particles contain gas and so have a bulk density lower than the density of the particles. This reduces the rate of settling. The fluid is particularly envisaged as a slickwater fracturing fluid in which the suspended particles are proppant. The small particle size and/or substantial surface area increases the amount of gas which can be retained within agglomerates and so enhances the buoyancy of the agglomerates. The end result is that a greater proportion of a hydraulic fracture is propped open.
摘要翻译: 井眼流体包括水性载体液体,悬浮在其中的疏水性颗粒材料和用于润湿颗粒表面的气体并将其作为附聚物结合在一起。 疏水性颗粒材料具有不大于200微米的特定最大体积中值粒径d 50和/或至少30m 2 / l的最小表面积。 颗粒的聚集体含有气体,因此其密度低于颗粒的密度。 这降低了沉降的速度。 流体特别设想为浮水压裂液,其中悬浮颗粒是支撑剂。 小的颗粒尺寸和/或实质的表面积增加了可以在聚集体内保留的气体的量,从而增强了附聚物的浮力。 最终的结果是水力裂缝的比例较大。
-
公开(公告)号:US08471136B2
公开(公告)日:2013-06-25
申请号:US13018186
申请日:2011-01-31
申请人: Michael Fuller
发明人: Michael Fuller
IPC分类号: G10H1/32
CPC分类号: G10H1/348 , G10H1/0091
摘要: An effects pedal including a first stage configured to asymmetrically limit an input signal, and a second stage configured to symmetrically clip the asymmetrically limited signal.
摘要翻译: 包括被配置为不对称地限制输入信号的第一级的效果踏板和被配置为对称地夹紧不对称限制的信号的第二级。
-
公开(公告)号:US20120048555A1
公开(公告)日:2012-03-01
申请号:US12868201
申请日:2010-08-25
申请人: Trevor Hughes , Evgeny Barmatov , Jill Geddes , Michael Fuller , Bruno Drochon , Sergey Makarychev-Mikhailov
发明人: Trevor Hughes , Evgeny Barmatov , Jill Geddes , Michael Fuller , Bruno Drochon , Sergey Makarychev-Mikhailov
CPC分类号: C09K8/665 , C09K8/70 , C09K8/805 , C09K2208/08 , C09K2208/28 , E21B43/267
摘要: A wellbore fluid comprising an aqueous carrier liquid, hydrophobic fibers suspended therein, hydrophobic particulate material also suspended in the carrier liquid, and a gas to wet the surfaces of the particles and fibers and bind them together as agglomerates. The wellbore fluid may be a slickwater fracturing fluid and may be used for fracturing a tight gas reservoir.Using a combination of hydrophobic particulate material, hydrophobic fibers and gas inhibits settling out of the particulate material from an aqueous liquid. Because the gas acts to wet the surfaces of both materials and agglomerates them, the particulate material is made to adhere to the fibers; the fibers form a network which hinders settling of the particulate material adhering to them, and the agglomerates contain gas and so have a bulk density which is less than the specific gravity of the solids contained in the agglomerates.
摘要翻译: 包含水性载体液体的疏水性流体,悬浮在其中的疏水性纤维,还悬浮在载体液体中的疏水性颗粒材料,以及气体以湿润颗粒和纤维的表面并将其作为附聚物结合在一起。 井筒流体可以是一个滑水压裂液,并可用于压裂一个紧密的气藏。 使用疏水性颗粒材料,疏水性纤维和气体的组合可以防止从水性液体中沉淀出颗粒物质。 因为这些气体用来润湿两种材料的表面并使它们聚集,所以使颗粒材料粘附到纤维上; 纤维形成阻碍粘附在其上的颗粒材料的沉降的网络,并且附聚物含有气体,因此其堆积密度小于附聚物中所含固体的比重。
-
公开(公告)号:US20120048554A1
公开(公告)日:2012-03-01
申请号:US12868177
申请日:2010-08-25
申请人: Trevor Hughes , Evgeny Barmatov , Jill Geddes , Michael Fuller , Bruno Drochon , Sergey Makarychev-Mikhailov
发明人: Trevor Hughes , Evgeny Barmatov , Jill Geddes , Michael Fuller , Bruno Drochon , Sergey Makarychev-Mikhailov
CPC分类号: C09K8/805 , C09K8/665 , C09K8/70 , C09K2208/28 , E21B43/267
摘要: A wellbore fluid comprises an aqueous carrier liquid, hydrophobic particulate material suspended therein and a gas to wet the surface of the particles and bind them together as agglomerates. The hydrophobic particulate material has a specified maximum particle size and/or minimum surface area: namely a volume median particle size d50 of not more than 200 micron, determined as median diameter of spheres of equivalent volume and/or a surface area of at least 30 m2 per liter (0.03 m2 per milliliter), determined as surface area of smooth spheres of equivalent volume.The agglomeration of the particles by gas leads to the formation of agglomerates which contain gas and so have a bulk density lower than the density of the particles. This reduces the rate of settling. The fluid is particularly envisaged as a slickwater fracturing fluid in which the suspended particles are proppant. We have found that the small particle size and/or substantial surface area increases the amount of gas which can be retained within agglomerates and so enhances the buoyancy of the agglomerates. The end result is that a greater proportion of a hydraulic fracture is propped open.
摘要翻译: 井眼流体包括水性载体液体,悬浮在其中的疏水性颗粒材料和用于润湿颗粒表面的气体并将其作为附聚物结合在一起。 疏水性颗粒材料具有规定的最大粒径和/或最小表面积:即体积中值粒径d50不大于200微米,确定为等体积的球体的中值直径和/或至少30的表面积 m2 /升(0.03平方米/毫升),确定为相当体积平滑球面的表面积。 通过气体的颗粒附聚导致形成含有气体的聚集体,因此其密度低于颗粒的密度。 这降低了沉降的速度。 流体特别设想为浮水压裂液,其中悬浮颗粒是支撑剂。 我们已经发现,小的颗粒尺寸和/或实质的表面积增加了可以在附聚物中保留的气体的量,并且因此增强了附聚物的浮力。 最终的结果是水力裂缝的比例较大。
-
公开(公告)号:US20070094536A1
公开(公告)日:2007-04-26
申请号:US11566029
申请日:2006-12-01
申请人: Erturk Kocalar , John Grossman , Michael Fuller
发明人: Erturk Kocalar , John Grossman , Michael Fuller
IPC分类号: G06F11/00
CPC分类号: G06F11/2733
摘要: Methods, systems, and computer program products for multiplexing a target communication port to provide an additional independent communication channel sharing at least some portion of hardware associated with the target port. Typically, a device, such as a disk drive, is also connected to the target port. An out-of-band signal indicates when the shared hardware is being used to provide the additional independent communication channel to avoid interfering with the target port device. A communication board with one or more communication ports may be coupled to the additional independent communication channel for communicating data from the target system to other devices or systems, such as a host system, through the communication board. In communicating with the target system, the communication board may emulate a particular interface that is supported by the target port. One type of host system may be a development system for designing, testing and debugging the target system.
摘要翻译: 用于复用目标通信端口以提供附加独立通信信道的方法,系统和计算机程序产品,共享与目标端口相关联的硬件的至少一部分。 通常,诸如磁盘驱动器的设备也连接到目标端口。 带外信号指示共享硬件何时被用于提供额外的独立通信信道,以避免干扰目标端口设备。 具有一个或多个通信端口的通信板可以耦合到附加的独立通信信道,用于通过通信板将目标系统的数据传送到诸如主机系统的其他设备或系统。 在与目标系统通信时,通信板可以模拟由目标端口支持的特定接口。 一种类型的主机系统可以是用于设计,测试和调试目标系统的开发系统。
-
公开(公告)号:US20070008523A1
公开(公告)日:2007-01-11
申请号:US11454923
申请日:2006-06-19
IPC分类号: G01J3/00
CPC分类号: G01J3/44 , B07C5/344 , G01J3/02 , G01J3/0264 , G01J3/28 , G01J3/2846 , G01J2003/4424 , G01N21/3563 , G01N21/3577 , G01N21/359 , G01N21/65 , G01N21/9508 , G01N2021/3595 , G01N2021/651 , G01N2201/129
摘要: A prescription verification system includes a database that contains a plurality of spectral signatures corresponding to identified pharmaceuticals. A multimodal multiplex sampling (MMS) spectrometer obtains a spectra of a pharmaceutical to be identified and verified. The pharmaceutical can be inside or out of a vial. The prescription verification system includes algorithms for matching spectra of pharmaceuticals to be verified obtaining using the MMS spectrometer to spectral signatures contained in the database corresponding to identified pharmaceuticals. The prescription verification system further includes algorithms for identifying such pharmaceuticals to be verified.
摘要翻译: 处方验证系统包括包含与所鉴定的药物对应的多个光谱特征的数据库。 多模式多重采样(MMS)光谱仪获得待鉴定和验证的药物的光谱。 药物可以在瓶子的内部或外部。 处方验证系统包括用于使用MMS光谱仪将待验证的药物光谱匹配到包含在与所鉴定的药物相对应的数据库中的光谱特征的算法。 处方验证系统还包括用于鉴定要验证的这种药物的算法。
-
-
-
-
-
-
-
-
-